TRF2 recruits the Werner syndrome (WRN) exonuclease for processing of telomeric DNA

Oncogene

Volumn 23, Issue 1, 2004, Pages 149-156

  Machwe, Amrita ^a   Xiao, Liren ^a   Orren, David K ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Aging; Cancer; Cellular senescence; RecQ helicases; Telomeres; Werner syndrome

Indexed keywords

DNA; EXONUCLEASE;

ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; ENZYME ACTIVITY; GENE; GENE INTERACTION; GENE STRUCTURE; GENETIC LINKAGE; HUMAN; NUCLEOTIDE REPEAT; PRIORITY JOURNAL; TELOMERE; TRF2 GENE; WERNER SYNDROME; WRN GENE;

BASE SEQUENCE; DNA; DNA HELICASES; EXONUCLEASES; MOLECULAR SEQUENCE DATA; RECQ HELICASES; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2; WERNER SYNDROME;

EID: 0942290416     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206906     Document Type: Article

References (32)

1. Ancelin K, Brunori M, Bauwens S, Koering C-E, Brun C, Ricoul M, Pommier J-P, Sabatier L and Gilson E. (2002). Mol. Cell. Biol., 22, 3474-3487.
2. Bianchi A, Smith S, Chong L, Elias P and de Lange T. (1997). EMBO J., 16, 1785-1794.
3. Bianchi A, Stansel RM, Fairall L, Griffith JD, Rhodes D and de Lange T. (1999). EMBO J., 18, 5735-5744.
4. Broccoli D, Smogorzewska A, Chong L and de Lange T. (1997). Nat. Genet., 17, 231-235.
5. Brosh RM, Orren DK, Nehlin JO, Ravn PH, Kenny MK, Machwe A and Bohr VA. (1999). J. Biol. Chem., 274, 18341-18350.
6. Chakraverty RK and Hickson ID. (1999). Bioessays, 21, 286-294.
7. Constantinou A, Tarsounas M, Karow JK, Brosh RM, Bohr VA, Hickson ID and West SC. (2000). EMBO Rep., 1, 80-84.
8. de Lange T. (2002). Oncogene, 21, 532-540.
9. Fukuchi K, Martin GM and Monnat RJ. (1989). Proc. Natl. Acad. Sci. USA, 86, 5893-5897.
10. Griffith JD, Comeau L, Rosenfield S, Stansel RM, Bianchi A, Moss H and de Lange T. (1999). Cell, 97, 503-514.
11. Hemann MT, Strong MA, Hao L-Y and Greider CW. (2001). Cell, 107, 67-77.
12. Johnson FB, Marciniak RA, McVey M, Stewart SA, Hahn WC and Guarente L. (2001). EMBO J., 20, 905-913.
13. Kamath-Loeb AS, Johannson E, Burgers PMJ and Loeb LA. (2000). Proc. Natl. Acad. Sci. USA, 97, 4603-4608.
14. Karlseder J, Smogorzewska A and de Lange T. (2002). Science, 295, 2446-2449.
15. Kim S-H, Kaminker P and Campisi J. (2002). Oncogene, 21, 503-511.
16. Lebel M, Spillare EA, Harris CA and Leder P. (1999). J. Biol. Chem., 274, 37795-37799.
17. Lundblad V. (2002). Oncogene, 21, 522-531.
18. Machwe A, Xiao L, Theodore S and Orren DK. (2002). J. Biol. Chem., 277, 4492-4504.
19. Martin GM, Sprague CR and Epstein CJ. (1970). Lab. Invest., 23, 86-92.
20. Maser RS and DePinho R. (2002). Science, 297, 565-569.
21. Opresko PL, von Kobbe C, Laine J-P, Harrigan J, Hickson ID and Bohr VA. (2002). J. Biol. Chem., 277, 41110-41119.
22. Orren DK, Brosh RM, Nehlin JO, Machwe A, Gray MD and Bohr VA. (1999). Nucleic Acids Res., 27, 3557-3566.
23. Orren DK, Theodore S and Machwe A. (2002). Biochemistry, 41, 13483-13488.
24. Oshima J. (2000). Bioessays, 22, 894-901.
25. Poot M, Hoehn H, Runger TM and Martin GM. (1992). Exp. Cell Res., 202, 267-273.
26. Schulz VP, Zakian VA, Ogburn CE, McKay J, Jarzebowicz AA, Edland SD and Martin GM. (1996). Hum. Genet., 97, 750-754.
27. Shay JW and Wright WE. (2001). Rad. Res., 155, 188-193.
28. Smogorzewska A, van Steensel B, Bianchi A, Oelmann S, Schaefer MR, Schnapp G and de Lange T. (2000). Mol. Cell Biol., 20, 1659-1668.
29. Stansel RM, de Lange T and Griffith JD. (2001). EMBO J., 20, 5532-5540.
30. Tahara H, Tokutake Y, Maeda S, Kataoka H, Watanabe T, Satoh M, Matsumoto T, Sugawara M, Ide T, Goto M, Furuichi Y and Sugimoto M. (1997). Oncogene, 15, 1911-1920.
31. Van Steensel B and de Lange T. (1997). Nature, 385, 740-743.
32. Wyllie FS, Jones CJ, Skinner JW, Haughton MF, Wallis C, Wynford-Thomas D, Faragher RGA and Kipling D. (2000). Nat. Genet., 24, 16-17.